| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $14.8M | +3.0% |
| Cost of Revenue | $13.6M | -10.4% |
| Gross Profit | $1.3M | +267.3% |
| R&D Expense | $586K | +0.0% |
| SG&A Expense | $2.5M | -19.2% |
| Operating Income | -$8.8M | +39.7% |
| Net Income | -$8.6M | +22.1% |
| EPS (Basic) | -$4.37 | -297.3% |
| EPS (Diluted) | -$4.37 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.4M | -80.9% |
| Accounts Receivable | $80K | — |
| Inventory | $2.5M | -1.0% |
| Current Assets | $4.9M | -53.0% |
| Total Assets | $16.2M | -37.3% |
| Current Liabilities | $2.2M | -40.1% |
| Long-term Debt | $500K | +0.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$6.9M | +1.4% |
| Capital Expenditures | $2.2M | -66.0% |
| Investing Cash Flow | -$1.6M | +14.6% |
| Financing Cash Flow | $2.4M | +1227.4% |
| Free Cash Flow | -$9.0M | +32.1% |
| -297.3% |
| Total Liabilities |
| $2.8M |
| -58.5% |
| Stockholders' Equity | $13.5M | -29.9% |